Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.60
-0.14-1.44%
Last update: Dec 5, 9:29 AM
Comments
Loading...
Intellia Therapeutics (NTLA) Stock Price, Quote, News & History
NTLANASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Intellia Therapeutics (NTLA) stock?
You can purchase shares of Intellia Therapeutics (NASDAQ:NTLA) through any online brokerage.
Who are Intellia Therapeutics (NTLA) competitors?
Other companies in Intellia Therapeutics’s space includes: ARS Pharmaceuticals Inc (NASDAQ:SPRY), MoonLake Immunotherapeutics (NASDAQ:MLTX), CureVac NV (NASDAQ:CVAC), CareDx Inc (NASDAQ:CDNA) and Xencor Inc (NASDAQ:XNCR).
What is the forecast, or price target, for Intellia Therapeutics (NTLA) stock?
Intellia Therapeutics has a consensus price target of $27.13.
What is the current price for Intellia Therapeutics (NTLA)?
The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $9.6 last updated December 5, 2025 at 9:29 AM EST.
Does Intellia Therapeutics (NTLA) pay a dividend?
There are no upcoming dividends for Intellia Therapeutics.
When is Intellia Therapeutics (NASDAQ:NTLA) reporting earnings?
Intellia Therapeutics does not have any upcoming earnings scheduled.
Is Intellia Therapeutics (NTLA) going to split?
There is no upcoming split for Intellia Therapeutics.
What sector and industry does Intellia Therapeutics (NTLA) operate in?
Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
